ATNM PEER ANALYSIS

Actinium Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

ATNMActinium Pharmaceuticals Inc

🇺🇸 USA · AMEX · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ATNMIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ATNM	RTALB	MSB	Ind. Median
P/E	—	4.89	—	17.91
P/B	13.30	0.61●	—	3.51
EV/EBITDA	—	74.61	—	14.82
P/S	340.49	6.67●	31.61	10.89

Financial Health
Metric	ATNM	RTALB	MSB	Ind. Median
Current Ratio	5.89●	1.21	—	5.90
Debt/Equity	65.9%	1.2%●	—	10.9%
NetDebt/EBITDA	1.79	0.90●	—	1.15

Profitability
Metric	ATNM	RTALB	MSB	Ind. Median
Net Margin	-26,078.9%	136.3%●	-115.3%	-125.7%
ROE	-167.7%	15.1%●	-11.3%	-47.5%
ROA	-41.1%	13.1%●	-8.6%	-35.8%
EBITDA Margin	-25,150.0%	9.0%●	-76.6%	-105.8%

Growth + Dividend
Metric	ATNM	RTALB	MSB	Ind. Median
Rev. Growth	-88.9%	24.0%	410.4%●	5.1%
NI Growth	—	134.0%	—	12.1%
Div. Yield	—	0.0%●	0.0%●	0.2%
Payout	—	0.0%	0.0%	0.0%

Valuation
Metric	ATNM	SGMO	OTLK	PDSB	PMVP	VRCA	Ind. Median
P/E	—	—	—	—	—	—	17.91
P/B	13.30	-1.52●	-1.27	12.16	0.74	4.07	3.51
EV/EBITDA	—	—	—	—	—	—	14.82
P/S	340.49	0.83●	110.89	—	—	1.76	10.89

Financial Health
Metric	ATNM	SGMO	OTLK	PDSB	PMVP	VRCA	Ind. Median
Current Ratio	5.89	0.70	0.54	2.26	11.14●	2.02	5.90
Debt/Equity	65.9%	-102.0%●	-93.8%	407.5%	0.3%	9.0%	10.9%
NetDebt/EBITDA	1.79	0.07	-0.31●	0.21	1.19	1.69	1.15

Profitability
Metric	ATNM	SGMO	OTLK	PDSB	PMVP	VRCA	Ind. Median
Net Margin	-26,078.9%	-356.9%	-18,297.5%	—	—	-48.0%●	-125.7%
ROE	-167.7%	—	—	-254.1%	-63.2%●	—	-47.5%
ROA	-41.1%●	-168.8%	-297.6%	-93.1%	-58.6%	-44.0%	-35.8%
EBITDA Margin	-25,150.0%	-339.9%	-18,634.1%	—	—	-30.6%●	-105.8%

Growth + Dividend
Metric	ATNM	SGMO	OTLK	PDSB	PMVP	VRCA	Ind. Median
Rev. Growth	-88.9%	-45.8%	-2.1%	-100.0%	—	417.6%●	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ATNM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.